Kyntra Bio, Inc. (0IL8.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.01M |
| Enterprise Value | 6.7M |
| P/E Ratio | 0.17 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 3.74 |
| Price/Book Ratio | -0.64 |
| Enterprise/Revenue | 1.36 |
| Enterprise/EBITDA | -0.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 21.99 |
| Operating Margin | -6.04 |
AD
Management Effectiveness
| Return On Assets | 1.49 |
| Return On Equity | -2.34 |
Income Statement
| Revenue | 6.44M |
| Revenue/Share | 1.84 |
| Gross Profit | 5.14M |
| EBITDA | -44.59M |
| Net Income | 130.9M |
| Diluted EPS | 45.36 |
Balance Sheet
| Total Cash | 87.24M |
| Total Cash/Share | 21.56 |
| Total Debt | 19.25M |
| Total Debt/Equity | -0.44 |
| Current Ratio | 3.61 |
| Book Value Per Share | -7.6 |
Price History
| 52-Week Change | -11.63 |
| 52-Week High | 20.8 |
| 52-Week Low | 0.34 |
| Moving Average 50 Days | 1.58 |
| Moving Average 200 Days | 2.79 |
Statistics
| Average Volume | 28,076 |
| Shares Outstanding | 4.05M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 17, 2025 |
AD
